Trial Information
Amino Acid Transport Imaging of Breast Carcinoma Via Anti-3-[18F]FACBC PET-CT: A Pilot Study
Inclusion Criteria:
1. Patients must be 18 years of age or older.
2. Patients will have a breast mass and/or lymph nodes naïve to therapy about to undergo
biopsy or post-biopsy pre-therapy. Patients with known or suspected recurrent disease
will be eligible for this protocol.
3. Ability to lie still for PET scanning
4. Patients must be able to provide written informed consent
Exclusion Criteria:
1. Age less than 18.
2. Inability to lie still for PET scanning.
3. Cannot provide written informed consent.
4. Current therapy for breast carcinoma.
5. Positive serum or urine pregnancy test within 24 hours of study.
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Presence of FACBC radiotracer in breast carcinoma on FACBC PET scan
Outcome Time Frame:
Outcomes will be assessed at the end of one year.
Safety Issue:
Yes
Authority:
United States: Food and Drug Administration
Study ID:
FACBCBr
NCT ID:
NCT01659645
Start Date:
August 2012
Completion Date:
Related Keywords:
- Breast Cancer
- Breast Neoplasms
Name | Location |
Emory University |
Atlanta, Georgia 30322 |